TABLE 5.
Strain used as vaccine for antiserum production | Strain used for absorption | Titer of H antibodies to straina:
|
||||||
---|---|---|---|---|---|---|---|---|
U5/41 | B99:H7U5/41 | A42 | B99:H7A42 | RH 3535 | B99:H7RH3535 | B99-2b | ||
U5/41 | None | 51,200 | 51,200 | 51,200 | 51,200 | 51,200 | 51,200 | — |
B99:H7U5/41 | — | — | — | — | — | — | NT | |
B99:H7A42 | 1,600 | 1,600 | — | — | — | — | NT | |
B99:H7RH3535 | 800 | 1,600 | — | — | — | — | NT | |
A42 | None | 25,600 | 25,600 | 25,600 | 25,600 | 25,600 | 25,600 | — |
B99:H7U5/41 | — | — | 1,600 | 1,600 | 1,600 | 1,600 | NT | |
B99:H7A42 | — | — | — | — | — | — | NT | |
B99:H7RH3535 | — | — | — | — | — | — | NT | |
RH 3535 | None | 6,400 | 6,400 | 6,400 | 6,400 | 6,400 | 6,400 | — |
B99:H7U5/41 | — | — | 200 | 400 | 400 | 400 | NT | |
B99:H7A42 | — | — | — | — | — | — | NT | |
B99:H7RH3535 | — | — | — | — | — | — | NT | |
B99:H7U5/41 | None | 25,600 | 25,600 | 25,600 | 25,600 | 25,600 | 25,600 | — |
U5/41 | — | — | — | — | — | — | NT | |
A42 | 800 | 1,600 | — | — | — | — | NT | |
RH 3535 | 800 | 800 | — | — | — | — | NT | |
B99:H7A42 | None | 25,600 | 25,600 | 25,600 | 25,600 | 25,600 | 25,600 | — |
U5/41 | — | — | 3,200 | 1,600 | 3,200 | 3,200 | NT | |
A42 | — | — | — | — | — | — | NT | |
RH 3535 | — | — | — | — | — | — | NT | |
B99:H7RH3535 | None | 12,800 | 12,800 | 12,800 | 12,800 | 12,800 | 12,800 | — |
U5/41 | — | — | 800 | 1,600 | 800 | 800 | NT | |
A42 | — | — | — | — | — | — | NT | |
RH 3535 | — | — | — | — | — | — | NT |
Reciprocal titer by the tube agglutination assay. Strains B99:H7U5/41, B99:H7A42, and B99:H7RH3535 were transductants isolated from recipient B99-2, which inherited their H antigens from wild donor strains U5/41, A42, and RH 3535, respectively. The starting dilution of the antisera was 1:25. —, titer less than 1:25; NT, not tested.
B99-2 was the recipient O55:H6 strain.